• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • About
  • A1Cs
  • Contact
  • Archives
  • Taming The Tiger
Scott's Diabetes

Scott's Diabetes

Helping you see your strength

PERL Study – Early Treatment for Diabetic Kidney Disease

December 16, 2014 By Scott K. Johnson 2 Comments

I am a believer in participating in clinical research.

It is an important part of medical progress, and if it weren’t for clinical research, we would be in pretty poor company when it comes to choices and options for the products and medicines we use to manage our diabetes.

I have received some of the best medical care of my life through clinical studies

For example, some years ago I had an opportunity to participate in a study at the University of Minnesota called the RASS Study. The study included two actual kidney biopsies, one at the start, and one at completion, five years later.

Can you imagine the peace of mind when Dr. Mauer told me my kidneys look great even after so many years with diabetes? Sign me up, all day, every day.

Participation is Key

I believe there is a misconception about clinical research. I think that people hear those words and get a little scared. They think that there is a lot of risk involved, and that they will be putting themselves in harm by participating.

Yes. There is some risk involved. There is always risk involved. But studies done at reputable institutions, like what you’ll find through clinicaltrials.gov, are designed with safety first on the list. Nobody wins if a volunteer is harmed during a trial.

And there are many benefits to participation.

  • Feeling of contributing to advancement of medicine and medical science.
  • Advanced and intensive medical care and screening, unlike anything you’d typically get through your normal doctor.
  • Early access to medications that may be beneficial (you have to weigh the risks here, as they may be unknown).
  • Free medication during the course of the study.
  • Sometimes even payment for participation.

PERL Study

Dr. Michael Mauer
Dr. Michael Mauer

Dr. Michael Mauer (University of Minnesota Medical School), and Dr. Alessandro Doria (Harvard Medical School & Joslin Diabetes Center) and their teams have asked for help in spreading the word about the PERL Study (Preventing Early Renal Loss in Diabetes). It’s a 3 year study and they are looking for about 480 people with type 1 diabetes to enroll. Candidates should be showing early signs of decreased kidney function on either blood or urine tests.

This is the only trial that is looking at early treatment options for diabetic kidney disease, which is very exciting.

Diabetic kidney disease continues to be, by far, the most significant cause of kidney failure in the USA. Slowing early progression could provide many years of additional good health. — Dr. Michael Mauer, University of MN

There are study centers in most areas of the Unites States and Canada, and travel costs will be paid for eligible participants. Please see the PERL Study website to learn more and find out if you might qualify.

PERL Study

Please spread the word if you might know someone who may be interested.

Filed Under: Blog Posts Tagged With: Clinical Research, Studies, University of Minnesota

guest
guest

This site uses Akismet to reduce spam. Learn how your comment data is processed.

2 Comments
Newest
Oldest Most Voted
Inline Feedbacks
View all comments

Primary Sidebar

Image of Scott K. Johnson
Scott K. Johnson

About Scott

Patient voice, speaker, writer, advocate. Living life with diabetes and telling my story. Patient Success Manager, USA for mySugr (All opinions expressed are my own and do not necessarily represent the position of my employer).

Diagnosed in April of 1980, I recognize the incredible mental struggle of living with diabetes. Read more…

Facebook | Twitter | LinkedIn

Footer

DISCLAIMER & POLICIES
I am not a medical professional. Nothing on this site is medical advice and is not meant to replace medical advice. Contact your doctor for questions about your health. All opinions expressed are my own and do not necessarily represent the position of my employer

Here are my advertising policies, disclosures & guidelines, privacy information, and terms & conditions.

  • Why is my hand so sticky?
  • He was the best I could ask for
  • #ScottsDeathRide 💀🚴‍♂️ – I rode 103.3 miles through Death Valley!
  • #ScottsDeathRide 💀🚴‍♂️ – weeks 13-15 – In a RUT!
  • #ScottsDeathRide – Raffle for sweet cycling gear!

Copyright © 2021

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

SAVE & ACCEPT